Ivermectin

What is Ivermectin? Ivermectin is a chemical that is mostly known as a type of insecticide that can kill the mites responsible for scabies and similar conditions in both humans and animals.

Ivermectin can also kill Demodex Mites, which has been linked to rosacea.

Ivermectin can be applied topically and also has an oral form, which is commonly used to treat mange in animals.

Galderma has been developing their own version of Ivermectin for over a decade and recently gained approval for Soolantra – a 1% Ivermectin cream formulated into Cetaphil Moisturizing Lotion. Soolantra is the FDA approved version of Ivermectin that can be used to treat rosacea.

For more information see the Soolantra Articles.

Recent Rosacea Blog Posts

Mirvaso to be a $100 million drug for Galderma

A revealing interview with the Galderma USA President Francois Fournier has just been published by the Dallas Fort Worth Healthcare Daily. This publication, `D HEALTHCARE Daily’ takes a keen interest in Galderma as the company’s US headquarters are in Forth Worth, TX. In the interview Fournier gives some interesting insights into the research and development […]

Continue Reading

Sklice, Topical Ivermectin 0.5% for Head Lice on Scalp and Hair

A new prescription topical ivermectin product called Sklice is being promoted in the United States. Sanofi Pasteur received FDA approval for Sklice as a treatment for Head Lice in humans. The interest for rosacea sufferers in topical ivermectin has been motivated by the large scale trials that Galderma is undertaking with CD5024. CD5024 is a […]

Continue Reading

Theory: Ivermectin is Metrogel’s Cousin, Help Needed

OK, bear with me. I don’t often just waffle here as a Rosacea News item. Maybe I should. Anyway this post is just me exploring an idea. From my high school organic chemistry it seems to me that Ivermectin and Metrondizole are in fact chemically akin to cousins. I started to think about this because […]

Continue Reading

The mysterious CD5024 1% Cream for which Galderma is conducting a large Phase III trial, has further been confirmed as the anti-parasitic Ivermectin. This latest confirmation comes from the World Heath Organisation’s International Clinical Trials Registry Platform Search Portal. The search for CD5024 reveals trials that have completed in the Czech Republic, Germany and Hungary. The […]

Continue Reading

This recently published patent is interesting for a couple of reasons. Firstly there is renewed interest in Ivermectin because of Galderma’s large trial of Topical Ivermectin 1% Cream (CD5024) for facial rosacea. Secondly there are few official treatments for ocular rosacea, so a provable treatment such as outlined in this patent could show promise. A […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.